Tags » Pharma

Clinical Trial Data Sharing Off to a Slow Start: A Rutgers paper in The New England Journal of Medicine explores why long-awaited access to drug trial data is underused

Clinical data-sharing is touted as key to accelerating medical discoveries, but a two-year-old sharing program is surprisingly underused.

For many years, doctors, scientists and researchers have urged that clinical drug trial data be shared to accelerate medical advances in treating multiple diseases. 194 more words

Rutgers Research

The impact of the FDA Combination Products Guidance on Nasal and Oral Inhalation Drug Products

The FDA draft guidance for combination products has a substantial impact on the development of Oral Inhalation and Nasal Drug Products (OINDPs) as it requires that the manufacturers have to be compliant not only with CGMPs for the drugs (21 CFR Parts 210 and 211) but also with the quality system (QS) regulations for devices (21 CFR Part 820).  195 more words



Boston Biomedical starts phase III study of Napabucasin

Boston Biomedical, an industry leader in the development of novel compounds designed to target cancer stemness pathways, announced dosing of the first patient in CanStem303C, a new global phase III study investigating napabucasin in combination with standard of care (Folfiri) in patients with previously treated metastatic colorectal carcinoma (mCRC). 382 more words

Dr Reddys Q2 net plummets 60% at Rs 308.9 cr

25/10/2016 17:32

Country’s secong largest drug maker Dr Reddys Laboratories Ltd on Tuesday reported a significant fall of 60.1 per cent in its consolidated net profit after taxes (PAT) at Rs 308.9 crore for the second quarter ended September 30, 2016. 151 more words


Prevent Gastric Cancer with Antibiotics

Antibiotics, a Life saver for Gastric Cancer Patients:

Antibiotic, a chemical compound that is responsible for killing, inhibiting, or retarding the growth of bacteria. It belongs to the wider group of antibacterial compounds, used to cure infections caused by the micro-organism, including fungi and protozoa. 454 more words


This Could Be the Next Blockbuster Drug for GlaxoSmithKline

GlaxoSmithKline has filed its shingles vaccine Shingrix for U.S. regulatory approval, the drugmaker said on Monday, bringing the potential $1 billion-a-year seller a step closer to market. 277 more words


Addictions, Sin and the Enslaved

“Stand fast therefore in the liberty wherewith Christ hath made us free, and be not entangled again with the yoke of bondage.”
–Galatians 5:1

Sin, though… 1,057 more words

End Time Deception